• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment with direct oral anticoagulants (DOACs) and secondary prophylaxis in patients affected by multiple episodes of superficial venous thrombosis.

作者信息

Laganà Alessandro, Sorella Silvia, Fucci Ludovica, Genoese Angelo, Chistolini Antonio

机构信息

Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Via Benevento 6, Rome 00161, Italy.

Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Via Benevento 6, Rome 00161, Italy.

出版信息

Eur J Intern Med. 2024 Apr;122:135-138. doi: 10.1016/j.ejim.2024.01.017. Epub 2024 Jan 19.

DOI:10.1016/j.ejim.2024.01.017
PMID:38245462
Abstract
摘要

相似文献

1
Treatment with direct oral anticoagulants (DOACs) and secondary prophylaxis in patients affected by multiple episodes of superficial venous thrombosis.直接口服抗凝剂（DOACs）治疗及对多发性浅静脉血栓形成患者的二级预防。
Eur J Intern Med. 2024 Apr;122:135-138. doi: 10.1016/j.ejim.2024.01.017. Epub 2024 Jan 19.
2
Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.内脏静脉血栓形成二级预防的长期抗凝治疗结果
Eur J Clin Invest. 2021 Jan;51(1):e13356. doi: 10.1111/eci.13356. Epub 2020 Aug 11.
3
Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic.新冠疫情期间直接口服抗凝剂用于内脏静脉血栓形成二级预防的真实世界经验
Ann Hematol. 2023 Jun;102(6):1607-1608. doi: 10.1007/s00277-023-05184-8. Epub 2023 Mar 25.
4
Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review.有血栓形成倾向、抗磷脂综合征或不常见部位静脉血栓形成患者中直接口服抗凝剂的应用：叙述性综述。
Blood Rev. 2018 Jul;32(4):272-279. doi: 10.1016/j.blre.2018.01.002. Epub 2018 Apr 20.
5
Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism.
Clin Appl Thromb Hemost. 2016 Apr;22(3):209-21. doi: 10.1177/1076029615600791. Epub 2015 Aug 31.
6
Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.静脉血栓栓塞的管理：口服抗凝治疗的最新进展
Ann Pharmacother. 2016 Jun;50(6):486-501. doi: 10.1177/1060028016632785. Epub 2016 Feb 25.
7
Mesoglycan for the secondary prevention of superficial vein thrombosis: a randomized, controlled, double-blind study (METRO Study)-rationale and protocol.透明质酸聚糖用于浅静脉血栓形成的二级预防：一项随机、对照、双盲研究（METRO 研究）——理论基础和方案。
J Thromb Thrombolysis. 2024 Feb;57(2):226-234. doi: 10.1007/s11239-023-02896-6. Epub 2023 Nov 6.
8
Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants.肺栓塞的抗凝治疗：直接口服抗凝剂时代的进展
Tech Vasc Interv Radiol. 2017 Sep;20(3):141-151. doi: 10.1053/j.tvir.2017.07.003. Epub 2017 Jul 5.
9
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients.直接口服抗凝剂用于静脉血栓栓塞症的二级预防：伴主要先天性血栓形成倾向与非血栓形成倾向患者的比较。
Intern Emerg Med. 2022 Jun;17(4):1081-1085. doi: 10.1007/s11739-021-02917-3. Epub 2022 Jan 11.
10
Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry.RIETE 登记研究中直接口服抗凝剂治疗孤立性远端深静脉血栓形成的管理。
J Thromb Thrombolysis. 2021 Aug;52(2):532-541. doi: 10.1007/s11239-020-02347-6. Epub 2020 Nov 28.

引用本文的文献

1
Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide.直接口服抗凝剂（DOAC）疗法在复杂临床场景中的挑战与机遇：全面综述与实用指南
J Clin Med. 2025 Apr 23;14(9):2914. doi: 10.3390/jcm14092914.